Glenn JS - Search Results

1

Mixing the right hepatitis C inhibitor cocktail.

Gelman MA, Glenn JS. Gelman MA, et al. Among authors: glenn js. Trends Mol Med. 2011 Jan;17(1):34-46. doi: 10.1016/j.molmed.2010.10.005. Epub 2010 Nov 23. Trends Mol Med. 2011. PMID: 21106440 Free PMC article. Review.

2

Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβ.

Rutaganira FU, Fowler ML, McPhail JA, Gelman MA, Nguyen K, Xiong A, Dornan GL, Tavshanjian B, Glenn JS, Shokat KM, Burke JE. Rutaganira FU, et al. Among authors: glenn js. J Med Chem. 2016 Mar 10;59(5):1830-9. doi: 10.1021/acs.jmedchem.5b01311. Epub 2016 Feb 26. J Med Chem. 2016. PMID: 26885694 Free PMC article.

3

Testing antivirals against hepatitis delta virus: farnesyl transferase inhibitors.

Bordier BB, Glenn JS. Bordier BB, et al. Among authors: glenn js. Methods Mol Med. 2004;96:539-53. doi: 10.1385/1-59259-670-3:539. Methods Mol Med. 2004. PMID: 14762290 No abstract available.

4

Novel therapies for hepatitis C virus based on lessons from virology.

Glenn JS. Glenn JS. Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S86-8. doi: 10.1016/s1542-3565(05)00703-2. Clin Gastroenterol Hepatol. 2005. PMID: 16234068 Review.

5

The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors.

Einav S, Sobol HD, Gehrig E, Glenn JS. Einav S, et al. Among authors: glenn js. J Infect Dis. 2010 Jul 1;202(1):65-74. doi: 10.1086/653080. J Infect Dis. 2010. PMID: 20486856 Free PMC article.

6

Hepatitis D in Children.

Xue MM, Glenn JS, Leung DH. Xue MM, et al. Among authors: glenn js. J Pediatr Gastroenterol Nutr. 2015 Sep;61(3):271-81. doi: 10.1097/MPG.0000000000000859. J Pediatr Gastroenterol Nutr. 2015. PMID: 25988557

7

Hepatitis delta infection - Current and new treatment options.

Elazar M, Koh C, Glenn JS. Elazar M, et al. Among authors: glenn js. Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):321-327. doi: 10.1016/j.bpg.2017.05.001. Epub 2017 May 22. Best Pract Res Clin Gastroenterol. 2017. PMID: 28774414 Review.

8

The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Pang PS, Planet PJ, Glenn JS. Pang PS, et al. Among authors: glenn js. PLoS One. 2009 Aug 11;4(8):e6579. doi: 10.1371/journal.pone.0006579. PLoS One. 2009. PMID: 19668364 Free PMC article.

9

The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein.

Lee C, Ma H, Hang JQ, Leveque V, Sklan EH, Elazar M, Klumpp K, Glenn JS. Lee C, et al. Among authors: glenn js. Virology. 2011 May 25;414(1):10-8. doi: 10.1016/j.virol.2011.03.026. Epub 2011 Apr 22. Virology. 2011. PMID: 21513964 Free PMC article.

10

Molecular virology of the hepatitis C virus: implication for novel therapies.

Glenn JS. Glenn JS. Clin Liver Dis. 2005 Aug;9(3):353-69, v. doi: 10.1016/j.cld.2005.05.013. Clin Liver Dis. 2005. PMID: 16023970 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters